Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG3BE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,794
Award facts
- Contract value 100% obligated
- $14,794.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,794.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 300 mg/2 mL Dupixent pens on January 7, 2026, with completion scheduled for January 8, 2026. Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe eczema, asthma, and other inflammatory conditions. This delivery order was competitively awarded with no set-aside designation and is being fulfilled from the company's place of performance in Conshohocken, Pennsylvania.
This delivery order is executed under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s broader Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion single-award vehicle running through December 2031 that provides global pharmaceutical and medical supply support for military healthcare programs. The IDC enables DLA to procure a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support military treatment facilities and veteran healthcare systems worldwide. AmerisourceBergen Drug Corp's established role as a major federal pharmaceutical distributor positions it to reliably fulfill urgent medical supply needs across the Defense Health Agency and other federal healthcare entities.
Quick answers
Who was awarded contract SPE2DR26FG3BE?
SPE2DR26FG3BE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FG3BE worth?
The government has obligated $14,794 on SPE2DR26FG3BE.
Is contract SPE2DR26FG3BE an order under another contract?
Yes. SPE2DR26FG3BE is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG3BE competed?
The extent of competition for SPE2DR26FG3BE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award